ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)

Clinical trial NCT00535730 · COMPLETED

Trial details

NCT number: NCT00535730
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Herpes Zoster Pneumococcal Infection

Start date: 2007-06-01
Primary completion: 2008-02-01
Enrollment: 473

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.